United Therapeutics (UTHR) Goodwill & Intangibles (2010 - 2026)

United Therapeutics has disclosed Goodwill & Intangibles across 17 years of filings, most recently posting $114.1 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles rose 2.33% year-over-year to $114.1 million; the TTM figure through Jun 2026 stood at $114.1 million (up 2.33% YoY), while the FY2025 annual figure was $116.5 million, up 4.11% from the prior year.
• Goodwill & Intangibles came in at $114.1 million for Q2 2026 at United Therapeutics, down from $115.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $116.7 million in Q3 2025 to a low of $44.4 million in Q3 2023.
• Average Goodwill & Intangibles over 5 years is $87.0 million, with a median of $111.8 million recorded in 2024.
• Year-over-year, Goodwill & Intangibles soared 159.33% in 2024 and declined 3.21% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $44.5 million in 2022, then jumped by 156.63% to $114.2 million in 2023, then decreased by 2.01% to $111.9 million in 2024, then increased by 4.11% to $116.5 million in 2025, then dropped by 2.06% to $114.1 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $114.1 million in Q2 2026, $115.5 million in Q1 2026, and $116.5 million in Q4 2025.